https://seekingalpha.com/article/4273070-ibm-big-blue-big-short
9 replies (most recent on top)
Re-brand it "Watson Van Damme" and sell to military.
1gko. Search for the guilty, punishment of the innocent, praises and honors for the non-participants
what will happen when watson k--ls its first patient
My problem with Watson - particularly for Oncology was Rometty and IBM's ludicrous claims were so inaccurate, which ultimately lead to unsafe and incorrect treatment recommendations. Think about that for a second.
To me its no different to the sorry saga of Theranos and Elizabeth Holmes, who currently faces fraud and conspiracy charges for allegedly misleading investors in her blood-testing start-up.
Meanwhile Rometty is still at too ... recently she said "Watson for Oncology is doing very well — very well" (@CES 2019)
I wish more tech media outlets and financial analysts would press hard on the question of how exactly IBM is going to monetize the Red Hat acquisition. The explanations from IBM never seem to get beyond "hybrid and multi cloud woooooooooooooo, Kubernetes woooooooooo, DevOps woooooooooo". If the idea is we're just going to package up a bunch of legacy software into Docker containers so that it can be deployed on AWS, Azure, GCP, or on-prem and orchestrate it with K8, well, we didn't need to spend $34B on that we could've just started doing it a couple of years ago. But I'm willing to admit I may be missing something.
Watson is just one of the many “strategic” investments Ginni made that were a failure and waste of billions of dollars. Odds are RH will be the same. Stockholders should be livid.
Good to see someone calling out Watson for what it is.
We are just one financial scandal away from a meltdown (that did GE in)
“Phytel was a really good company, it was really strong. Many people who got laid off are disappointed because they helped build this company and they really thought IBM would take it to the next level—not destroy it within three years.”